Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice
General Info
Coverage type
Country
Time period covered
January, 2014 - December, 2014
Data type
Scientific literature
Citation
Journal
Pharmacogenomics
Pages
2007-18
Publication year
2015
Suggested citation
Schackman BR, Haas DW, Park SS, Li XC, Freedberg KA. Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice. Pharmacogenomics. 2015; 16(18): 2007-18.